Join the Oncology Voice Network. Join for Free
Recruiting for Impact: Inside the Oncology Talent Market
recruiting oncology recruiting

Recruiting for Impact: Inside the Oncology Talent Market


Share This Article



Summary

Get the real story on oncology recruiting: Michael Pietrack explains the hiring disconnects and strategies behind top-performing executive teams.

 

Think the best oncology leadership teams just happen?

 

In this episode of the Oncology Voice Network podcast, host Dr. Kirk Shepard sits down with executive search leader Michael Pietrack for a candid exploration of what really fuels effective executive hiring in oncology drug development.

 

Discover why time perception differences between candidates and hiring managers often derail the process, how the traditional "buyer and seller" interview dynamic actually works, and why so many companies end up hiring from the same limited pool—risking cultural homogeneity and stunted growth. Michael Pietrack shares how companies can avoid these pitfalls, the signals exec hiring sends to the marketplace, and why siloed decision-making holds organizations back.

 

From must-know insights on evaluating leadership teams and structuring consensus interviews, to the real-world value of external recruiters and how oncology biotechs are outbidding big pharma for top talent, this episode is loaded with practical, industry-shaping advice.

 

Watch on YouTube
talent, oncology recruiting, top oncology talent

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
How to Create a GREAT MSL Team Culture
Partner Avatar MSL Talk: Tom Caravela, Chad Fellers

How to Create a GREAT MSL Team Culture

Podcast
How to successfully recruit and hire MSLs VIRTUALLY with Paula Pearson
Partner Avatar MSL Talk: Tom Caravela, Paula Pearson

How to successfully recruit and hire MSLs VIRTUALLY with Paula Pearson

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Podcast
Hiring Managers Beware: Reverse Rejection Explained!
Partner Avatar Michael Pietrack

Hiring Managers Beware: Reverse Rejection Explained!

Article
Clinical Educator Oncology Program Improves Adherence by 29%​
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%​

Explore OVN